- Home
- Member Resources
- Articles
-
Tissue provenance is the concept of assuring that tissue, whether in a container, on a slide or a swab, or in an instrument, is from the original source and authentic.
-
Find 10 practical tips for early-career pathologists to lead quality improvement (QI) initiatives in healthcare settings. this article by Jennifer Woo, MD, FCAP highlights how QI can enhance diagnostic accuracy, streamline lab workflows, and foster interdepartmental collaboration even without formal leadership roles.
-
Explore how exosomes are advancing liquid biopsy technology, offering new possibilities for cancer diagnostics, monitoring, and personalized treatment strategies.
-
Immunohistochemical (IHC) markers can serve as surrogates for molecular genetic events, providing a practical tool for early and accurate diagnosis. These markers are particularly useful in soft tissue tumor pathology, where both benign and malignant neoplasms often have defining genetic events that result in protein overexpression or loss.
-
Explore the intricate relationship between Clonal Hematopoiesis of Indeterminate Potential (CHIP), inflammation, and cardiovascular disease. Learn about the genetic mutations involved, factors affecting CHIP, and potential therapeutic strategies to mitigate associated risks.
-
While allogenic cellular therapies (ACTs) offer promising off-the-shelf treatment options, addressing challenges in their development and implementation is essential for improving their safety, efficacy, and accessibility to a broader patient population.
-
The guideline, "Human Papillomavirus (HPV) Testing in Head and Neck Carcinomas," published in Archives of Pathology & Laboratory Medicine, reflects the latest research and technological advancements to improve diagnostic accuracy and patient outcomes.
-
By integrating personal and professional endeavors, you can have your cake and eat it too. Pathology on the Coast is a rare opportunity to learn about current pathology topics in the morning and enjoy leisure and relaxation in the afternoon.
-
Genetic and molecular testing are revolutionizing the diagnosis and treatment of salivary gland neoplasms, aiding in tumor classification, prognostication, and targeted therapy selection. This article explores key diagnostic biomarkers, emerging therapeutic targets, and the challenges of molecular testing, highlighting its growing role in precision oncology for these rare and heterogeneous tumors.
-
While once a distant possibility, the advancement of DNA methylation techniques is now bringing the potential for a pan-cancer DNA methylation classifiers closer to realization.
-
Navigating the job market and visa processes can be challenging; learn about the visa options available for pathology residents and the requirements and benefits of each.
-
Dr. Victor Cabañas and Dr. Anthony Victorio discuss how their Filipino upbringing and culture influenced their experiences and careers in pathology.
-
Pathologists who specialize in clinical informatics (also known as pathology informaticists or pathology informaticians) serve as medical directors for laboratory information systems and/or the laboratory components of electronic health records (EHRs). Are you interested in pursuing clinical informatics? Learn more.
-
Review the five key takeaways from the CAP's recent webinar on the differences between FDA and CLIA risk classifications of laboratory-developed tests.
-
The College of American Pathologists (CAP) filed an amicus brief on against the Food and Drug Administration (FDA) and its regulation of laboratory-developed tests (LDTs), challenging the LDT rulemaking by the FDA, which acted arbitrarily and capriciously in violation of the Administrative Procedure Act.
-
Pathology student interest groups (SIGs) provide a valuable platform for medical students to explore the field of pathology, gain exposure to various subspecialties, connect with experienced pathologists, and build a supportive community of like-minded peers.